EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today announced it will release its fourth quarter and full year 2011 financial results before the market opens on Monday, March 12, 2012, and host a conference call shortly thereafter at 8:00 a.m. ET (Eastern Time) to discuss the results. Paul K. Wotton, Ph.D., President and Chief Executive Officer, and Robert F. Apple, Executive Vice President and President of the Parenteral Products Division, will host the call.
